| # | Drug | Count |
|---|---|---|
| 0 | PEGFILGRASTIM | 6943 |
| 1 | ADALIMUMAB | 3712 |
| 2 | ALBUTEROL SULFATE | 3203 |
| 3 | BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE | 2806 |
| 4 | INSULIN GLARGINE | 2617 |
| 5 | SECUKINUMAB | 2578 |
| 6 | NEMOLIZUMAB-ILTO | 2529 |
| 7 | GOLIMUMAB | 2499 |
| 8 | ABATACEPT | 2488 |
| 9 | SOMATROPIN | 2429 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PEGFILGRASTIM-CBQV | 915 | 0.6381 |
| 1 | PEGFILGRASTIM | 6943 | 0.5796 |
| 2 | ADALIMUMAB-AQVH | 28 | 0.2828 |
| 3 | ACLIDINIUM BROMIDE | 1282 | 0.2006 |
| 4 | GOLIMUMAB | 2499 | 0.1984 |
| 5 | CICLOPIROX OLAMINE | 79 | 0.1660 |
| 6 | NEMOLIZUMAB-ILTO | 2529 | 0.1588 |
| 7 | NITRIC OXIDE | 660 | 0.1426 |
| 8 | ALBUTEROL SULFATE AND BUDESONIDE | 179 | 0.1119 |
| 9 | ADALIMUMAB-ADBM | 26 | 0.0970 |
| # | Drug class | Count |
|---|---|---|
| 0 | Leukocyte Growth Factor [EPC] | 7891 |
| 1 | Corticosteroid [EPC] | 5396 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 4552 |
| 3 | Insulin Analog [EPC] | 3640 |
| 4 | Interleukin-17A Antagonist [EPC] | 2656 |
| 5 | Interleukin-31 Receptor alpha Antagonist [EPC] | 2529 |
| 6 | Interleukin-23 Antagonist [EPC] | 2496 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 2488 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2230 |
| 9 | GLP-1 Receptor Agonist [EPC] | 1497 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-31 Receptor alpha Antagonist [EPC] | 2529 | 0.1588 |
| 1 | Interleukin-17A Antagonist [EPC] | 2656 | 0.0712 |
| 2 | Interleukin-5 Antagonist [EPC] | 46 | 0.0669 |
| 3 | Leukocyte Growth Factor [EPC] | 7891 | 0.0553 |
| 4 | Provitamin D2 Compound [EPC] | 1032 | 0.0347 |
| 5 | PCSK9 Inhibitor [EPC] | 661 | 0.0257 |
| 6 | Interleukin-23 Antagonist [EPC] | 2496 | 0.0238 |
| 7 | Recombinant Human Growth Hormone [EPC] | 506 | 0.0230 |
| 8 | Guanylate Cyclase-C Agonist [EPC] | 43 | 0.0207 |
| 9 | Interferon alfa-2b [EPC] | 37 | 0.0199 |